Zoltan Szallasi

Citado por

	Total	Desde 2020
Citas	47431	20722
Índice h	83	51
Índice i10	188	130

4800

2400

1200

3600

199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025161 182 251 259 245 254 256 209 263 326 482 653 792 712 852 927 1284 1797 1917 2247 2513 2835 3150 3513 4094 4711 4342 3701 3415 447

Acceso público

Ver todo

130 artículos

5 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Aron Charles EklundClinical Microbiomics A/SDirección de correo verificada de clinical-microbiomics.com
Nicolai Juul BirkbakProfessor, Department of Molecular Medicine (MOMA), Aarhus UniversityDirección de correo verificada de clin.au.dk
Charles SwantonFrancis Crick InstituteDirección de correo verificada de crick.ac.uk
Qiyuan LiSchool of Medicine, Xiamen UniversityDirección de correo verificada de xmu.edu.cn
Andrea L RichardsonAssociate Professor of Pathology and Oncology, Johns Hopkins University School of MedicineDirección de correo verificada de jhmi.edu
Marcin KrzystanekAssistant Professor, Technical University of DenmarkDirección de correo verificada de cbs.dtu.dk
Istvan CsabaiProfessor of Physics, Eötvös University, BudapestDirección de correo verificada de elte.hu
Balázs Győrffy MD PhDClarivate Highly Cited, Semmelweis, PTE, HUN-REN, ELIXIR, Hungarian Academy of SciencesDirección de correo verificada de ttk.mta.hu
Joerg StellingDepartment of Biosystems Science and Engineering, ETH ZurichDirección de correo verificada de inf.ethz.ch
Andrea Marion MarquardPostdoc, Technical University of DenmarkDirección de correo verificada de dtu.dk
Nicholas McGranahanGroup Leader, CRUK Lung Cancer Centre of Excellence, UCL Cancer InstituteDirección de correo verificada de ucl.ac.uk
Julian DownwardFrancis Crick InstituteDirección de correo verificada de crick.ac.uk
Scott L. CarterDana-Farber Cancer InstituteDirección de correo verificada de broadinstitute.org
Andrew J RowanPrincipal Laboratory Research Scientist, Francis Crick InstituteDirección de correo verificada de crick.ac.uk
Francesco FaveroCopenhagen UniversityDirección de correo verificada de bric.ku.dk
Vipul PeriwalNIHDirección de correo verificada de mail.nih.gov
Christian Bowman-ColinModerna Inc.Dirección de correo verificada de modernatx.com
James LarkinRoyal Marsden Hospital / Institute of Cancer Research, London, UKDirección de correo verificada de rmh.nhs.uk
Prof Marco GerlingerBarts Cancer Institute, London, UKDirección de correo verificada de qmul.ac.uk
Maik KschischoProfessor for AI in HealthcareDirección de correo verificada de uni-koblenz.de

Seguir

Zoltan Szallasi

Harvard Medical School

Dirección de correo verificada de childrens.harvard.edu


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing M Gerlinger, AJ Rowan, S Horswell, J Larkin, D Endesfelder, E Gronroos, ... New England journal of medicine 366 (10), 883-892, 2012	8937	2012
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients B Györffy, A Lanczky, AC Eklund, C Denkert, J Budczies, Q Li, Z Szallasi Breast cancer research and treatment 123, 725-731, 2010	2966	2010
The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. L Shi, LH Reid, WD Jones, R Shippy, JA Warrington, SC Baker, PJ Collins, ... Nature biotechnology 24 (9), 1151-1161, 2006	2446	2006
Tracking the evolution of non–small-cell lung cancer M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ... New England Journal of Medicine 376 (22), 2109-2121, 2017	2384	2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ... Nature 545 (7655), 446-451, 2017	1859	2017
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers SL Carter, AC Eklund, IS Kohane, LN Harris, Z Szallasi Nature genetics 38 (9), 1043-1048, 2006	1349	2006
Robustness of cellular functions J Stelling, U Sauer, Z Szallasi, FJ Doyle, J Doyle Cell 118 (6), 675-685, 2004	1297	2004
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer DP Silver, AL Richardson, AC Eklund, ZC Wang, Z Szallasi, Q Li, N Juul, ... Journal of clinical oncology 28 (7), 1145-1153, 2010	1290	2010
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution EC De Bruin, N McGranahan, R Mitter, M Salm, DC Wedge, L Yates, ... Science 346 (6206), 251-256, 2014	1288	2014
Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer ML Telli, KM Timms, J Reid, B Hennessy, GB Mills, KC Jensen, Z Szallasi, ... Clinical cancer research 22 (15), 3764-3773, 2016	1010	2016
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. B Győrffy, A Lánczky, Z Szállási Endocrine-related cancer 19 (2), 197-208, 2012	895	2012
Neoantigen-directed immune escape in lung cancer evolution R Rosenthal, EL Cadieux, R Salgado, MA Bakir, DA Moore, CT Hiley, ... Nature 567 (7749), 479-485, 2019	827	2019
Reliability and reproducibility issues in DNA microarray measurements S Draghici, P Khatri, AC Eklund, Z Szallasi TRENDS in Genetics 22 (2), 101-109, 2006	792	2006
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data F Favero, T Joshi, AM Marquard, NJ Birkbak, M Krzystanek, Q Li, ... Annals of Oncology 26 (1), 64-70, 2015	757	2015
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution N McGranahan, F Favero, EC De Bruin, NJ Birkbak, Z Szallasi, ... Science translational medicine 7 (283), 283ra54-283ra54, 2015	741	2015
Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ... Cell 173 (3), 595-610. e11, 2018	621	2018
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents NJ Birkbak, ZC Wang, JY Kim, AC Eklund, Q Li, R Tian, C Bowman-Colin, ... Cancer discovery 2 (4), 366-375, 2012	605	2012
Chromosomal instability confers intrinsic multidrug resistance AJX Lee, D Endesfelder, AJ Rowan, A Walther, NJ Birkbak, PA Futreal, ... Cancer research 71 (5), 1858-1870, 2011	541	2011
Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal TJ Mitchell, S Turajlic, A Rowan, D Nicol, JHR Farmery, T O’Brien, ... Cell 173 (3), 611-623. e17, 2018	526	2018
Ca (2+)-dependent and Ca (2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory … K Ozawa, Z Szallasi, MG Kazanietz, PM Blumberg, H Mischak, ... Journal of Biological Chemistry 268 (3), 1749-1756, 1993	481	1993

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores